Auvelity has developed a newly approved treatment for people with early-onset Alzheimer’s disease, specifically developed to reduce agitation — one of the most challenging and emotionally distressing symptoms for both patients and caregivers. This campaign speaks to those who make medical decisions for their loved ones, highlighting the reality that treating agitation doesn’t have to mean sedation or disconnection. With Auvelity, patients can experience relief from agitation while maintaining their ability to stay present, engaged, and emotionally connected. The message is simple yet powerful: by easing agitation without suppressing personality, Auvelity helps preserve dignity — so your loved one can keep living in the moment, and you can keep sharing the ones that matter most.

Version 1

For many, a parent or grandparent with early-onset Alzheimer’s isn’t just family, they’re a superhero: someone we’ve looked up to, learned from, and idolized throughout our lives. This perspective inspired our creative concept, “Stay Super.” The campaign positions Auvelity as a way to help preserve the dignity and presence of the hero we’ve always known by reducing agitation without sedation, it empowers patients to remain engaged, emotionally connected, and true to themselves.